Related references
Note: Only part of the references are listed.Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201
Yasuhiro Tsutani et al.
ANNALS OF THORACIC SURGERY (2019)
Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma
Koji Kameda et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC
Daniel Morgensztern et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The IASLC Lung Cancer Staging Project Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
Ramon Rami-Porta et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Nathan M. Mollberg et al.
ANNALS OF THORACIC SURGERY (2014)
Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer
Yasuhiro Tsutani et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma
Yasuhiro Tsutani et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
Lymphovascular Invasion in Non-Small-Cell Lung Cancer Implications for Staging and Adjuvant Therapy
Kristin A. Higgins et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Effect of Postoperative Adjuvant Chemotherapy with Tegafur-Uracil on Survival in Patients with Stage IA Non-small Cell Lung Cancer An Exploratory Analysis from a Meta-Analysis of Six Randomized Controlled Trials
Chikuma Hamada et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non-Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
Gary M. Strauss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp
Y Nagai et al.
CANCER RESEARCH (2005)
Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer
C Hamada et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
